Collaboration Agreements in the Biotechnology Industry

1,119 Contracts & Agreements

Browse by Company

4D Molecular Therapeutics Inc (3 contracts)
ACADIA PHARMACEUTICALS INC (1)
ACCELERON PHARMA INC (4)
Acorda Therapeutics (2)
Acumen Pharmaceuticals, Inc. (2)
Adagio Therapeutics, Inc. (1)
Adaptimmune Therapeutics PLC (5)
Adhera Therapeutics, Inc. (1)
ADURO BIOTECH, INC. (2)
Advaxis, Inc. (4)
Adverum Biotechnologies, Inc. (4)
AGENUS INC (1)
AGIOS PHARMACEUTICALS INC (1)
Aimmune Therapeutics, Inc. (3)
AKCEA THERAPEUTICS, INC. (5)
Akebia Therapeutics, Inc. (3)
Alector, Inc. (3)
Alkermes plc. (4)
Allogene Therapeutics, Inc. (3)
Allovir, Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (26)
ALPINE IMMUNE SCIENCES, INC. (1)
Amgen Inc. (16)
AMICUS THERAPEUTICS, INC. (10)
AmpliPhi Biosciences Corp (3)
ANAPTYSBIO INC (5)
ANAVEX LIFE SCIENCES CORP. (2)
Anixa Biosciences Inc (6)
Aptevo Therapeutics Inc. (6)
Aptinyx Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
Aravive, Inc. (1)
ARCA biopharma, Inc. (12)
Arcturus Therapeutics Holdings Inc. (1)
Arcus Biosciences, Inc. (2)
Arcutis Biotherapeutics, Inc. (1)
ARENA PHARMACEUTICALS INC (1)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (4)
Arsanis, Inc. (1)
Artiva Biotherapeutics, Inc. (3)
ASSEMBLY BIOSCIENCES, INC. (1)
Atara Biotherapeutics, Inc. (4)
Athenex, Inc. (1)
ATHERSYS, INC (5)
Atreca, Inc. (1)
aTYR PHARMA INC (1)
AVEO PHARMACEUTICALS INC (4)
Avidity Biosciences, Inc. (1)
BeiGene, Ltd. (6)
BELLICUM PHARMACEUTICALS, INC (1)
BICYCLE THERAPEUTICS Ltd (7)
BioAtla, Inc. (3)
BIOCEPT INC (7)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOMARIN PHARMACEUTICAL INC (1)
BioXcel Therapeutics, Inc. (1)
bluebird bio, Inc. (4)
Blueprint Medicines Corp (11)
BridgeBio Pharma, Inc. (2)
C4 Therapeutics, Inc. (3)
CALADRIUS BIOSCIENCES, INC. (1)
Calithera Biosciences, Inc. (1)
CAPRICOR THERAPEUTICS, INC. (1)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
Caribou Biosciences, Inc. (12)
Castle Creek Biosciences, Inc. (3)
CATALYST BIOSCIENCES, INC. (5)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (4)
Cellular Biomedicine Group, Inc. (1)
Century Therapeutics, Inc. (6)
Checkmate Pharmaceuticals, Inc. (1)
Checkpoint Therapeutics, Inc. (2)
ChemoCentryx, Inc. (2)
CHIMERIX INC (1)
Cibus Global, Ltd. (1)
Cidara Therapeutics, Inc. (1)
Clovis Oncology, Inc. (3)
CM Life Sciences III Inc. (1)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (1)
Consonance-HFW Acquisition Corp. (1)
CONSTELLATION PHARMACEUTICALS INC (2)
Corbus Pharmaceuticals Holdings, Inc. (1)
CRISPR Therapeutics AG (6)
CTI BIOPHARMA CORP (2)
Cue Biopharma, Inc. (14)
Cullinan Oncology, LLC (3)
CURIS INC (5)
Cyclacel Pharmaceuticals, Inc. (4)
CytoDyn Inc. (2)
Cytokinetics, Incorporated (12)
CytomX Therapeutics, Inc. (16)
Decibel Therapeutics, Inc. (1)
Denali Therapeutics Inc. (3)
DiaMedica Therapeutics Inc. (1)
Dicerna Pharmaceuticals Inc (7)
Diffusion Pharmaceuticals Inc. (1)
DYADIC INTERNATIONAL INC (2)
Dynamics Special Purpose Corp. (2)
DYNAVAX TECHNOLOGIES CORP (2)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (3)
Editas Medicine, Inc. (4)
Eiger BioPharmaceuticals, Inc. (3)
Elevation Oncology, Inc. (3)
Entrada Therapeutics, Inc. (2)
ENZON PHARMACEUTICALS, INC. (8)
Epizyme, Inc. (12)
Equillium, Inc. (6)
Esperion Therapeutics, Inc. (6)
Evelo Biosciences, Inc. (1)
Exelixis (45)
EXICURE, INC. (2)
FATE THERAPEUTICS INC (2)
Fibrocell Science, Inc. (3)
FIBROGEN INC (3)
FIVE PRIME THERAPEUTICS INC (21)
Flex Pharma, Inc. (1)
Foghorn Therapeutics Inc. (1)
Forma Therapeutics Holdings, Inc., (1)
Forty Seven, Inc. (1)
Frequency Therapeutics, Inc. (1)
Fusion Pharmaceuticals Inc. (5)
GALECTIN THERAPEUTICS INC (2)
Generation Bio Co. (1)
GENETHERA INC (1)
GENOCEA BIOSCIENCES, INC. (1)
Genprex, Inc. (2)
Gilead Sciences (3)
Global Blood Therapeutics, Inc. (1)
GLYCOMIMETICS INC (1)
Gritstone Oncology, Inc. (2)
GTX INC (8)
Harpoon Therapeutics, Inc. (6)
Hillstream BioPharma Inc. (1)
Homology Medicines, Inc. (5)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (1)
iBio, Inc. (2)
IDEAYA Biosciences, Inc. (11)
IDERA PHARMACEUTICALS, INC. (6)
IGM Biosciences, Inc. (1)
Immix Biopharma, Inc. (1)
IMMUNOGEN INC (8)
IMMUNOMEDICS INC (3)
Incyte (7)
INOVIO PHARMACEUTICALS, INC. (6)
Intellia Therapeutics, Inc. (1)
INTREXON CORP (19)
Intrinsic Medicine, Inc. (1)
IO Biotech, Inc. (2)
IONIS PHARMACEUTICALS INC (28)
IRONWOOD PHARMACEUTICALS INC (4)
iTeos Therapeutics, Inc. (2)
Janux Therapeutics, Inc. (1)
Keros Therapeutics, Inc. (1)
Kindred Biosciences, Inc. (1)
Kiromic Biopharma, Inc. (2)
Kronos Bio, Inc. (1)
Kura Oncology, Inc. (1)
Kymera Therapeutics, Inc. (4)
LEAP THERAPEUTICS, INC. (2)
LEXICON PHARMACEUTICALS, INC. (8)
LianBio (6)
Ligand Pharmaceuticals Incorporated (2)
Locust Walk Acquisition Corp. (1)
LogicBio Therapeutics, Inc. (1)
Lyell Immunopharma, Inc. (3)
MACROGENICS INC (3)
MADRIGAL PHARMACEUTICALS, INC. (3)
Magenta Therapeutics, Inc. (8)
MANNKIND CORP (2)
MeiraGTx Holdings plc (2)
Mersana Therapeutics, Inc. (16)
Merus N.V. (1)
MIRAGEN THERAPEUTICS, INC. (11)
Mirati Therapeutics, Inc. (4)
Moderna, Inc. (2)
Molecular Templates, Inc. (5)
Momenta Pharmaceuticals, Inc. (6)
Monte Rosa Therapeutics, Inc. (1)
Morphic Holding, Inc. (9)
MYMETICS CORP (2)
Myriad Genetics, Inc. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (2)
NEUROCRINE BIOSCIENCES INC (9)
NEWLINK GENETICS CORP (7)
NextCure, Inc. (1)
Nkarta, Inc. (3)
NOVAVAX INC (5)
Nuo Therapeutics, Inc. (1)
Nurix Therapeutics, Inc. (8)
Olema Pharmaceuticals, Inc. (3)
Olivia Ventures, Inc. (2)
OncoCyte Corp (1)
ONCOSEC MEDICAL Inc (1)
Opko Health, Inc. (2)
ORAGENICS INC (8)
ORGANOVO HOLDINGS, INC. (1)
Orgenesis Inc. (2)
Oric Pharmaceuticals, Inc. (1)
Ovid Therapeutics Inc. (3)
Pasithea Therapeutics Corp. (4)
Passage BIO, Inc. (12)
PDL BIOPHARMA, INC. (1)
PIERIS PHARMACEUTICALS, INC. (15)
PORTOLA PHARMACEUTICALS INC (3)
Poseida Therapeutics, Inc. (1)
Praxis Precision Medicines, Inc. (1)
PRECISION BIOSCIENCES INC (4)
Prometheus Biosciences, Inc. (1)
Protagonist Therapeutics, Inc (6)
PROTEOSTASIS THERAPEUTICS, INC. (6)
PTC THERAPEUTICS, INC. (5)
PUMA BIOTECHNOLOGY, INC. (1)
Pyxis Oncology, Inc. (1)
RAPT Therapeutics, Inc. (3)
RECURSION PHARMACEUTICALS, INC. (3)
Regeneron Pharmaceuticals (19)
REGENXBIO Inc. (1)
Regulus Therapeutics Inc. (4)
Relay Therapeutics, Inc. (3)
RenovaCare, Inc. (1)
Repare Therapeutics Inc. (9)
Replimune Group, Inc. (2)
Retrophin, Inc. (2)
REXAHN PHARMACEUTICALS, INC. (5)
Rezolute, Inc. (2)
Rich Pharmaceuticals, Inc. (2)
RIGEL PHARMACEUTICALS INC (4)
Sage Therapeutics, Inc. (1)
SANGAMO THERAPEUTICS, INC (12)
Sarepta Therapeutics, Inc. (11)
Savara Inc (3)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (19)
SERA PROGNOSTICS, INC. (1)
Seres Therapeutics, Inc. (3)
Sesen Bio, Inc. (1)
Shattuck Labs, Inc. (2)
Sigilon Therapeutics, Inc. (2)
Silverback Therapeutics, Inc. (2)
Solid Biosciences Inc. (1)
SOLIGENIX, INC. (3)
Sorrento Therapeutics, Inc. (1)
SpringWorks Therapeutics, Inc. (3)
SQZ Biotechnologies Co (2)
SUNESIS PHARMACEUTICALS INC (3)
SUTRO BIOPHARMA, INC. (3)
Syndax Pharmaceuticals Inc (5)
SYNLOGIC, INC. (1)
Synthetic Biologics, Inc. (5)
Syros Pharmaceuticals, Inc. (3)
T2 Biosystems, Inc. (3)
Taysha Gene Therapies, Inc. (2)
TG THERAPEUTICS, INC. (1)
Tonix Pharmaceuticals Holding Corp. (1)
Tracon Pharmaceuticals, Inc. (1)
Translate Bio, Inc. (3)
TScan Therapeutics, Inc. (2)
Turning Point Therapeutics, Inc. (1)
Ultragenyx Pharmaceutical Inc. (18)
uniQure N.V. (3)
United Therapeutics Corp (1)
Unum Therapeutics Inc. (1)
VACCINEX, INC. (1)
Vaccitech plc (1)
VBI Vaccines Inc (3)
Verastem, Inc. (2)
Verve Therapeutics, Inc. (1)
VICAL INC (2)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (17)
VistaGen Therapeutics, Inc. (3)
Voyager Therapeutics, Inc. (2)
Werewolf Therapeutics, Inc. (1)
WINDTREE THERAPEUTICS INC (6)
Xencor Inc (8)
Xenetic Biosciences, Inc. (1)
Xenon Pharmaceuticals Inc. (2)
XOMA Corp (8)
YIELD10 BIOSCIENCE, INC. (1)
Zai Lab Ltd (6)
ZIOPHARM ONCOLOGY INC (1)
Zymeworks Inc. (3)

Recent Contracts

Amendment No. 4 to Clinical Trial Collaboration and Supply Agreement (Pfizer Agreement), dated as of May 12, 2023, by and between Pfizer Inc. and IDEAYA Biosciences, Inc (IDEAYA Biosciences, Inc., Filed With SEC on August 10, 2023)
Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement (Second Pfizer Agreement), dated as of May 12, 2023, by and between Pfizer Inc. and IDEAYA Biosciences, Inc (IDEAYA Biosciences, Inc., Filed With SEC on August 10, 2023)
Collaboration Agreement by and between the Registrant and Amgen, Inc., dated as of May 8, 2023 (TScan Therapeutics, Inc., Filed With SEC on August 10, 2023)
Amendment No. 3 dated April 27, 2023 to the Collaboration and License Agreement by and between the Registrant and BicycleTx Limited dated July 9, 2021. Portions of this exhibit... (IONIS PHARMACEUTICALS INC, Filed With SEC on August 9, 2023)
Letter Agreement dated June 29, 2023 in reference to the Collaboration and License Agreement dated December 6, 2021 by and between Akcea Therapeutics, Inc. and AstraZeneca AB.... (IONIS PHARMACEUTICALS INC, Filed With SEC on August 9, 2023)
Collaboration and License Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018) (Equillium, Inc., Filed With SEC on August 9, 2023)
Fourth Amendment to Collaboration and License Agreement by and between the registrant and Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated May 12, 2023 (Repare Therapeutics Inc., Filed With SEC on August 9, 2023)
Amendment No. AR4 to Amended and Restated Collaboration and License Agreement, by and between the Registrant and D.E. Shaw Research, LLC, dated March 22, 2023 (Relay Therapeutics, Inc., Filed With SEC on August 8, 2023)
Amendment No. 3 to the Collaboration and License Agreement, dated as of May 18, 2023, by and between CytomX Therapeutics, Inc. and Amgen, Inc (CytomX Therapeutics, Inc., Filed With SEC on August 8, 2023)
Amendment No. 2 to the Option, License and Collaboration Agreement, dated May 15, 2023, between Arcus Biosciences, Inc. and Gilead Sciences, Inc (Arcus Biosciences, Inc., Filed With SEC on August 7, 2023)
Amendment No. 13 to Collaboration and License Agreement, effective as of May 16, 2023, between Ultragenyx Pharmaceutical Inc. and Kyowa Kirin, Co., Ltd (Ultragenyx Pharmaceutical Inc., Filed With SEC on August 4, 2023)
First Amendment to Amended and Restated License and Collaboration Agreement by and between the Registrant and Aventis Pharmaceuticals Inc., dated May 1, 2013 (Regeneron Pharmaceuticals, Filed With SEC on August 3, 2023)
First Amendment to Collaboration and License Agreement, dated January 30, 2023, by and between the Company and Janssen Biotech, Inc (Xencor Inc, Filed With SEC on August 3, 2023)
Letter Agreement Amending the 2021 Collaboration and License Agreement between the Registrant and Glaxo Wellcome UK Ltd. dated May 19, 2023 (Alector, Inc., Filed With SEC on August 3, 2023)
Amendment No. 1 to Collaboration and License Agreement, dated as of June 5, 2023, between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc. d/b/a Proteovant... (Blueprint Medicines Corp, Filed With SEC on August 2, 2023)
Amendment No. 2 to Collaboration and License Agreement, dated as of July 27, 2023, between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc. d/b/a Proteovant... (Blueprint Medicines Corp, Filed With SEC on August 2, 2023)
Research and Development Collaboration and License Agreement by and between the Company and Applied Biomedical Science Institute dated July 5, 2023 (Hillstream BioPharma Inc., Filed With SEC on July 11, 2023)
License and Collaboration Agreement, executed and delivered as of June 19, 2023, by and between Santhera, its wholly-owned subsidiary, Santhera Pharmaceuticals (Schweiz) AG, and... (CATALYST PHARMACEUTICALS, INC., Filed With SEC on June 23, 2023)
License and Collaboration Agreement, dated (C4 Therapeutics, Inc., Filed With SEC on May 30, 2023)
Collaboration Agreement, dated August 10, 2020, by and between Adimab, LLC and Flame Biosciences, Inc (LEAP THERAPEUTICS, INC., Filed With SEC on May 15, 2023)
Letter Agreement II to the Collaboration Agreement and the Development Services and Clinical Supply Agreement, dated March 30, 2023, by and between the Registrant and Catalent... (Passage BIO, Inc., Filed With SEC on May 11, 2023)
Letter Agreement I to the Collaboration Agreement and the Development Services and Clinical Supply Agreement, dated March 30, 2023, by and between the Registrant and Catalent... (Passage BIO, Inc., Filed With SEC on May 11, 2023)
License and Collaboration Agreement, dated February 13, 2023, by and between the Registrant and Harbour BioMed US Inc (Cullinan Oncology, LLC, Filed With SEC on May 11, 2023)
Amendment No. 2 to the Research Collaboration Agreement, dated March 8, 2023, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Nkarta, Inc., Filed With SEC on May 11, 2023)
Strategic Collaboration and License Agreement, dated December 7, 2022, by and between the Registrant and Vertex Pharmaceuticals Incorporated (Entrada Therapeutics, Inc., Filed With SEC on May 10, 2023)
Collaboration and License Agreement, dated March 23, 2023, by and between the registrant and ModernaTX, Inc (Generation Bio Co., Filed With SEC on May 10, 2023)
Amendment 2 to the Collaboration and Commercial License Agreement, dated August 12, 2016, by and between Mersana Therapeutics, Inc. and Merck KGaA (Mersana Therapeutics, Inc., Filed With SEC on May 9, 2023)
Amendment 3 to the Collaboration and Commercial License Agreement, dated February 28, 2017, by and between Mersana Therapeutics, Inc. and Merck KGaA (Mersana Therapeutics, Inc., Filed With SEC on May 9, 2023)
Amendment 1 to the Collaboration and Commercial License Agreement, dated June 1, 2016, by and between Mersana Therapeutics, Inc. and Merck KGaA (Mersana Therapeutics, Inc., Filed With SEC on May 9, 2023)
Amended and Restated Clinical Collaboration and Supply Agreement, by and between the Registrant and Novartis Institutes for BioMedical Research, Inc., dated January 13, 2022 (Olema Pharmaceuticals, Inc., Filed With SEC on May 9, 2023)
Collaboration and Commercial License Agreement, dated June 23, 2014, by and between Mersana Therapeutics, Inc. and Merck KGaA (Mersana Therapeutics, Inc., Filed With SEC on May 9, 2023)
Second Amendment to Collaboration Agreement dated (BeiGene, Ltd., Filed With SEC on May 4, 2023)
Collaboration and Licence Agreement, dated March 27, 2023, by and between BicycleTx Limited and Novartis Pharma AG (BICYCLE THERAPEUTICS Ltd, Filed With SEC on May 4, 2023)
License and Research Collaboration Agreement by and between ModeX Therapeutics, Inc., OPKO Health, Inc. (with respect to certain sections), and Merck Sharp & Dohme LLC dated March... (Opko Health, Inc., Filed With SEC on May 3, 2023)
Second Amendment to Collaboration Agreement, entered into as of February 26, 2023, by and between Amgen Inc. and BeiGene Switzerland GmbH, and BeiGene, Ltd (Amgen Inc., Filed With SEC on April 28, 2023)
First Amendment to License and Collaboration Agreement, dated as of February 28, 2023 by and between LianBio Respiratory Limited and Landos BioPharma, Inc (LianBio, Filed With SEC on March 28, 2023)
License and Collaboration Agreement, dated as of February 28, 2023, by and between LianBio Development (HK) Limited and NImmune Biopharma, Inc (LianBio, Filed With SEC on March 28, 2023)
Continuing Clinical Collaboration Letter Agreement (LEAP THERAPEUTICS, INC., Filed With SEC on March 16, 2023)
Collaboration and License Agreement between the registrant and Genentech, Inc. and F. Hoffmann-La Roche Ltd., dated January 6, 2023 (Kronos Bio, Inc., Filed With SEC on March 15, 2023)
Collaboration and Option Agreement, dated November 12, 2020, by and between Yield10 Bioscience, Inc. and Rothamsted Research Institute, as amended (YIELD10 BIOSCIENCE, INC., Filed With SEC on March 14, 2023)